Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance

Overview of attention for article published in Journal of Clinical Investigation, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 3 public wall posts from 3 users.

Tumor-derived galectin-1 promotes an immunosuppressive barrier at the tumor endothelium https://buff.ly/32HhXYo An…

Tumor-derived galectin-1 promotes an immunosuppressive barrier at the tumor endothelium https://buff.ly/32HhXYo An…

Tumor-derived galectin-1 promotes an immunosuppressive barrier at the tumor endothelium https://buff.ly/32HhXYo An…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.